Tag Archives: Ivermectin

Ivermectin vs. Merck’s New Antiviral, Molnupiravir

In the video above retired nurse lecturer John Campbell, Ph.D., reports on a comparative analysis of molnurpirivir and ivermectin published in the Austin Journal of Pharmacology and Therapeutics.1 The first is Merck’s new antiviral drug and the second is the much vilified and maligned2,3 antiparasitic drug used in humans since 19874 and approved for human… Read More »

What we know about Ivermectin

Unlike the huge amount of high-quality data we have gathered on vaccines (5.6 billion doses and counting), the available data on Ivermectin is a dog’s breakfast – despite the fact that millions of people around the world have used it to treat COVID, especially in poor countries. The hope that Ivermectin could vanquish COVID was… Read More »